Brundin et al. evaluated the orexin levels in the cerebrospinal fluid (CSF) of 66 suicidal patients with MDD, dysthymia, and adjustment disorder in their human research on the relationship between depression and the orexin system. This evidence concerns the gene HCRT and depressive symptom measurement.